Pathogen Reduction of Platelets: Patient Safety and FDA Platelet Bacterial Guidance Compliance
The FDA’s 2021 deadline to implement their bacterial risk control and mitigation guidance is rapidly approaching. This webinar provides an overview of pathogen reduction’s (PR) impact on patient safety and streamlining compliance with the FDA guidances for reducing transfusion transmission risks.
Richard J. Benjamin, MD PhD FRCPath
Chief Medical Officer